Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Type of study
Language
Affiliation country
Publication year range
1.
Toxicol Pathol ; 32(2): 250-7, 2004.
Article in English | MEDLINE | ID: mdl-15200164

ABSTRACT

Effects of dietary administration of 1'-acetoxychavicol acetate (ACA) and the novel synthetic retinoids 4-[1-hydroxy-3-oxo-3-(5,6,7,8-tetrahydro-3-hydroxy-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid (Re-80); 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido]benzoic acid (Am-580); and 6-[(3,5-di-tert-butylphenyl) carbamoyl]nicotinic acid (Am-55P) were examined using a two-stage rat carcinogenesis model. A total of 190 female SD rats was treated sequentially with 1,2-dimethylhydrazine (DMH, s.c.); 7,12-dimethylbenz(a)anthracene (DMBA, i.g.); and 2,2'-dihydroxy-di-n-propylnitrosamine (DHPN, in the drinking water) during the first three weeks (DDD-initiation), and an additional 60 rats received the vehicle alone (non-initiation). One week after the completion of the initiation period, they were divided into nine groups and administrated Re-80 (at dose levels of 1.0 or 0.4 ppm), Am-580 (20 or 4 ppm), Am-55P (20 ppm), ACA (100 ppm), all-trans-retinoic acid (10 or 2 ppm) or no supplement in the diet for 33 weeks, until survivors were euthanatized at week 37 weeks. After DDD-initiation, all-trans-retinoic acid at the high dose delayed the development of mammary tumors. The multiplicity of colon tumors in the group fed Am-55P and the incidences of nephroblastomas with ACA or Am-580 were decreased as compared with the control values, but the other chemicals had no modifying effects on tumor development in any organs. Thus, among ACA and the novel synthetic retinoids tested, only Am-55P showed a weak inhibitory effect on a neoplasm of general interest under the present experimental conditions.


Subject(s)
Antineoplastic Agents/therapeutic use , Benzoates/therapeutic use , Carcinogens/toxicity , Neoplasms, Experimental/prevention & control , Plant Extracts/therapeutic use , Retinoids/therapeutic use , Terpenes/therapeutic use , Tetrahydronaphthalenes/therapeutic use , Administration, Oral , Animals , Benzyl Alcohols , Carcinogens/administration & dosage , Disease Models, Animal , Female , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/pathology , Rats , Rats, Sprague-Dawley , Water Supply
2.
J Toxicol Sci ; 27(1): 57-68, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11915369

ABSTRACT

The potential of purple sweet potato color (PSPC) and red cabbage color (RCC), natural anthocyanin food colors, to modify colorectal carcinogenesis was investigated in male F344/DuCrj rats, initially treated with 1,2-dimethylhydrazine (DMH) and receiving 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the diet. After DMH initiation, PSPC and RCC were given at a dietary level of 5.0% in combination with 0.02% PhIP until week 36. No PSPC or RCC-treatment-related changes in clinical signs and body weight were found. Incidences and multiplicities of colorectal adenomas and carcinomas in rats initiated with DMH were clearly increased by PhIP. In contrast, lesion development was suppressed by RCC, or tended to be inhibited by PSPC administration. Furthermore, in the non-DMH initiation groups, induction of aberrant crypt foci (ACF) by PhIP was significantly decreased by RCC supplementation. The results thus demonstrate that while PhIP clearly exerts promoting effects on DMH-induced colorectal carcinogenesis, these can be reduced by 5.0% PSPC or 5.0% RCC in a diet under the present experimental conditions.


Subject(s)
Adenoma/prevention & control , Anthocyanins/therapeutic use , Anticarcinogenic Agents/therapeutic use , Brassica/chemistry , Carcinoma/prevention & control , Colorectal Neoplasms/prevention & control , Ipomoea batatas/chemistry , Plant Preparations/therapeutic use , 1,2-Dimethylhydrazine/toxicity , Adenoma/chemically induced , Adenoma/pathology , Administration, Oral , Animals , Anthocyanins/administration & dosage , Anticarcinogenic Agents/administration & dosage , Carcinogens/toxicity , Carcinoma/chemically induced , Carcinoma/pathology , Cocarcinogenesis , Colon/drug effects , Colon/pathology , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/pathology , Diet , Hyperplasia/chemically induced , Hyperplasia/pathology , Imidazoles/toxicity , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Male , Plant Preparations/administration & dosage , Precancerous Conditions/chemically induced , Precancerous Conditions/pathology , Precancerous Conditions/prevention & control , Rats , Rats, Inbred F344
3.
Teratog Carcinog Mutagen ; 22(1): 41-50, 2002.
Article in English | MEDLINE | ID: mdl-11754386

ABSTRACT

The modifying potential of two Kampo medicines (Japanese traditional herbal medicines), Sho-saiko-to (TJ-9) and Sairei-to (TJ-114), on urinary bladder carcinogenesis in male F344 rats initiated with N-butyl-N-(4-hydroxybutyl)- nitrosamine (BBN) was evaluated. Groups of 20 animals were given 0.05% BBN in their drinking water for 4 weeks and then 0.7 or 2.8% TJ-9, 0.9 or 3.6% TJ-114, or 3.0% sodium bicarbonate (NaHCO(3)) as a positive control substance in their diet for 32 weeks. All rats were killed after 36 weeks and examined histopathologically. No adverse effects of the test compounds were found in terms of survival, clinical sign, and body weight. Administration of 0.7 and 2.8% TJ-9 and 0.9 and 3.6% TJ-114 in the diet did not affect the incidences or extent of PN hyperplasia in the BBN-treated rats. Incidences and multiplicities of papillomas were also not affected in rats fed 0.7 or 2.8% TJ-9 and 0.9% TJ-114, while they were significantly decreased in animals given 3.6% TJ-114 in the diet. The results thus demonstrated that neither of the test chemicals exerted any promotional activity on urinary bladder carcinogenesis, in clear contrast to NaHCO(3). In addition, bladder carcinogenesis was reduced by 3.6% TJ-114 in the diet, under the present experimental conditions.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Butylhydroxybutylnitrosamine/toxicity , Drugs, Chinese Herbal/pharmacology , Papilloma/chemically induced , Urinary Bladder Neoplasms/chemically induced , Animals , Hyperplasia , Male , Papilloma/pathology , Papilloma/urine , Rats , Rats, Inbred F344 , Steroids , Urinary Bladder/pathology , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/urine
SELECTION OF CITATIONS
SEARCH DETAIL